Amson Vaccines & Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private vaccine and pharmaceutical manufacturer · Islamabad · Pakistan
Islamabad-based manufacturer of vaccines, pharmaceutical products and medical consumables.
Amson Vaccines & Pharma products in Pakistan
Amson Vaccines & Pharma (Pvt.) Ltd has 123 medicine presentations registered in Pakistan under 63 brands, covering 55 generic medicines. Most of its products are in Anti-infectives, Vitamins, minerals & nutrition and Vaccines & immunologicals. Its brands with the most registered strengths and packs are Cesod (Ceftriaxone), Amsonate (Methylprednisolone), Amvax B (Hepatitis B vaccine (recombinant HBsAg)) and Ciprox (Ciprofloxacin). 123 products have an official DRAP price on MedInfoBase. See all 63 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- AMSON Vaccines & Pharma (Pvt.) Ltd.
- Company type
- Private vaccine and pharmaceutical manufacturer
- Address
- Plot No. 154, Industrial Triangle, Kahuta Road, Islamabad 44000, Pakistan · 44000
- Website
- amson.org.pk ↗
- Phone
- +92 51 4491492-3; +92 51 4490359
- info@amson.org.pk
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Amson Vaccines & Pharma (Pvt.) Ltd is priced against the market
98 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Amsozide-100 | Isoniazid | 100 mg | Tablet | 1000's | 025435 | PKR 346.17 | PKR 0.35/tablet | 🔒 Pharma Pro |
| Amvax B | Hepatitis B vaccine (recombinant HBsAg) | 10 mcg/0.5 mL | Injection | 0.5ml x 10's | 018727 | PKR 3,524.23 | PKR 704.85/mL | 🔒 Pharma Pro |
| Amvax B | Hepatitis B vaccine (recombinant HBsAg) | 20 mcg/1 mL | Vaccine injection | 1.0ml x 10's | 018727 | PKR 5,589.60 | PKR 558.96/mL | No comparator |
| Amvax B | Hepatitis B vaccine (recombinant HBsAg) | 10 mcg/0.5 mL | Injection | 0.5ml x 1's | 018727 | PKR 352.41 | PKR 704.82/mL | 🔒 Pharma Pro |
| Amvax B | Hepatitis B vaccine (recombinant HBsAg) | 20 mcg/1 mL | Vaccine injection | 1.0ml x 1's | 018727 | PKR 558.95 | PKR 558.95/mL | No comparator |
| Awzi | Azithromycin | 200 mg/5 mL | Suspension | 25 ml | 029973 | PKR 543.62 | PKR 21.74/mL | 🔒 Pharma Pro |
| Awzi | Azithromycin | 250 mg | Capsule | 6's | 029974 | PKR 310.64 | PKR 51.77/capsule | 🔒 Pharma Pro |
| Awzi | Azithromycin | 250 mg | Capsule | 10's | 029974 | PKR 516.43 | PKR 51.64/capsule | 🔒 Pharma Pro |
| Bett | Tetanus toxoid adsorbed vaccine | >40 IU/0.5 mL | Injection | 0.5ml vial / One dose vial | 083350 | PKR 79.17 | — | No comparator |
| BettSource observed | — | — | Injection | 5ml vial (Ten Dose) | 089969Official source ↗ | No indexed price | — | — |
| Cardrin | Acetylsalicylic acid (Aspirin) | 75 mg | Tablet | 1x30's | 017340 | PKR 48.47 | PKR 1.62/tablet | 🔒 Pharma Pro |
| Cardrin | Acetylsalicylic acid (Aspirin) | 150 mg | Tablet | 1x30's | 017341 | PKR 73.23 | PKR 2.44/tablet | 🔒 Pharma Pro |
| Cardrin | Acetylsalicylic acid (Aspirin) | 81 mg | Tablet | 30's | 048996 | PKR 55.23 | PKR 1.84/tablet | 🔒 Pharma Pro |
| Ceftapen | Ceftazidime | 250 mg | Injection | vial | 029059 | PKR 194.15 | PKR 194.15/vial/unit | 🔒 Pharma Pro |
| Ceftapen | Ceftazidime | 1 g | Injection | vial | 029060 | PKR 627.11 | PKR 627.11/vial/unit | 🔒 Pharma Pro |
| Cesod | Ceftriaxone | 250 mg | Injection | vial | 113055 | PKR 153.35 | PKR 153.35/vial/unit | 🔒 Pharma Pro |
| Cesod | Ceftriaxone | 250 mg | IV injection | 1's | 113056 | PKR 153.35 | PKR 153.35/vial/unit | 🔒 Pharma Pro |
| Cesod | Ceftriaxone | 500 mg | IV injection | 1 vial | 113057 | PKR 258.11 | PKR 258.11/vial/unit | 🔒 Pharma Pro |
| Cesod | Ceftriaxone | 1 g | IV injection | 1's | 113058 | PKR 487.37 | PKR 487.37/vial/unit | 🔒 Pharma Pro |
| Cesod | Ceftriaxone | 2 g | IV injection | 1 vial | 113059 | PKR 683.23 | PKR 683.23/vial/unit | 🔒 Pharma Pro |
| CESOD 1g IV InjectionRegistry verified | Ceftriaxone | — | — | — | 010180-EXOfficial source ↗ | No indexed price | — | — |
| Cesod 1gm IV InjectionRegistry verified | Ceftriaxone (as sodium) | — | — | — | 033750Official source ↗ | No indexed price | — | — |
| CESOD 2g IV InjectionRegistry verified | Ceftriaxone | — | — | — | 010181-EXOfficial source ↗ | No indexed price | — | — |
| Cesod 2gm IM InjectionRegistry verified | Ceftriaxone | — | — | — | 052404Official source ↗ | No indexed price | — | — |
| Cesod 2gm IV InjectionRegistry verified | Ceftriaxone (as sodium) | — | — | — | 052403Official source ↗ | No indexed price | — | — |
| CESOD 500 mg IV InjectionRegistry verified | Ceftriaxone | — | — | — | 010179-EXOfficial source ↗ | No indexed price | — | — |
| Cesod 500mg IV InjectionRegistry verified | Ceftriaxone (as sodium) | — | — | — | 033749Official source ↗ | No indexed price | — | — |
| Cesod Injection IM 1gmRegistry verified | Ceftriaxone | — | — | — | 046168Official source ↗ | No indexed price | — | — |
| Ciprox | Ciprofloxacin | 250 mg | Tablet | 10's | 017351 | PKR 367.99 | PKR 36.80/tablet | 🔒 Pharma Pro |
| Ciprox | Ciprofloxacin | 500 mg | Tablet | 10's | 017352 | PKR 647.68 | PKR 64.77/tablet | 🔒 Pharma Pro |
| Ciprox | Ciprofloxacin | 100 mg | Tablet | 1x10's | 037529 | PKR 99.10 | PKR 9.91/tablet | 🔒 Pharma Pro |
| Ciprox | Ciprofloxacin | 750 mg | Tablet | 1x10's | 037530 | PKR 396.42 | PKR 39.64/tablet | 🔒 Pharma Pro |
| ComBe Five | Diphtheria + Tetanus + Pertussis + Hepatitis B + Haemophilus influenzae type b vaccine | 25 Lf + 5.5 Lf + 16 IOU + 12.5 mcg HBsAg + 11 mcg Hib PRP per 0.5 mL | Vaccine injection | 1ml vial (Two dose) | 089966 | PKR 6,488.61 | — | No comparator |
| ComBe FiveSource observed | Diphtheria + Tetanus + Pertussis + Hepatitis B + Haemophilus influenzae type b vaccine | 30 IU | Vaccine injection | 2.5 ml vial (Five dose) | 089967Official source ↗ | No indexed price | — | — |
| ComBe FiveSource observed | — | 30 IU | Vaccine injection | 5ml vial (Ten Dose) | 089968Official source ↗ | No indexed price | — | — |
| Curoxime | Cefuroxime | 250 mg | Injection | 5 vial | 029056 | PKR 275.69 | PKR 55.14/vial/unit | 🔒 Pharma Pro |
| Curoxime | Cefuroxime | 750 mg | Injection | vial | 029057 | PKR 192.27 | PKR 192.27/vial/unit | 🔒 Pharma Pro |
| Curoxime | Cefuroxime | 1.5 g | Injection | vial | 029058 | PKR 348.85 | PKR 348.85/vial/unit | 🔒 Pharma Pro |
| Damex Cough | Aminophylline + Diphenhydramine + Ammonium chloride + Menthol | 32 mg + 8 mg + 30 mg + 0.98 mg/5 mL | Syrup | 120ml | 017347 | PKR 87.72 | PKR 0.73/mL | No comparator |
| Damex Cough | Aminophylline + Diphenhydramine + Ammonium chloride + Menthol | 32 mg + 8 mg + 30 mg + 0.98 mg/5 mL | Syrup | 60ml | 017347 | PKR 45.95 | PKR 0.77/mL | No comparator |
| Damex Cough | Aminophylline + Diphenhydramine + Ammonium chloride + Menthol | 32 mg + 8 mg + 30 mg + 0.98 mg/5 mL | Syrup | 450ml | 017347 | PKR 311.33 | PKR 0.69/mL | No comparator |
| DTwP-rHepB-Hib VaccineSource observed | (1 dose Vial) TetanusToxoid 5.5 LF ( | 60 IU | Injection | 1 dose vial containing 0.5ml | 077530Official source ↗ | No indexed price | — | — |
| DTwP-rHepB-Hib VaccineSource observed | (1 dose Vial) TetanusToxoid 5.5 LF ( | 60 IU | Injection | 1 dose vial containing 0.5ml | 077530Official source ↗ | No indexed price | — | — |
| Entvir | Entecavir | 0.5 mg | Tablet | 3x10's | 066594 | PKR 19,803.30 | PKR 660.11/tablet | 🔒 Pharma Pro |
| Esomepral 20 mg CapsulesRegistry verified | Esomeprazole | — | — | — | 043332Official source ↗ | No indexed price | — | — |
| Esomepral 40 mg CapsulesRegistry verified | Esomeprazole | — | — | — | 043333Official source ↗ | No indexed price | — | — |
| Euvichol-Plus | Cholera vaccine (inactivated, oral; Vibrio cholerae O1 and O139) | 1.5 mL dose | Oral suspension vaccine | 1's Plastic Tube | 107916 | PKR 1,117.58 | — | No comparator |
| Famotid TabRegistry verified | Famotidine | — | — | — | 017387Official source ↗ | No indexed price | — | — |
| Fanim-5 | Folic acid | 5 mg | Tablet | 500's | 021612 | PKR 159.34 | PKR 0.32/tablet | 🔒 Pharma Pro |
| Fanim-5 | Folic acid | 5 mg | Tablet | 100's | 021612 | PKR 115.09 | PKR 1.15/tablet | 🔒 Pharma Pro |
All 63 Amson Vaccines & Pharma brands in Pakistan
- Airflo Montelukast · 10 mg tablet
- Airflo Chewable Montelukast · 4 mg tablet, 5 mg tablet
- Albendal Albendazole · 200 mg tablet
- Amchoram-4 Chlorpheniramine · 4 mg tablet
- Amdoxine Pyridoxine HCl · 50 mg tablet
- Amfen Ibuprofen · 200 mg tablet, 400 mg tablet
- Amfer Ferrous sulfate · 200 mg tablet
- Amflu Fluconazole · 150 mg capsule, 50 mg/5 mL suspension
- Amoxcine Amoxicillin · 125 mg/5 mL suspension, 250 mg/5 mL suspension
- Amsim Simvastatin · 10 mg tablet, 20 mg tablet
- Amsofen Diclofenac · 25 mg tablet, 50 mg tablet
- Amsoflour 20 Fluoxetine · 20 mg capsule
- Amsol Paracetamol · 500 mg tablet
- Amsol-C Paracetamol + Codeine · 500 mg + 15 mg tablet
- Amsoline Amoxicillin · 500 mg capsule
- Amsonate Methylprednisolone · 1 g injection, 125 mg injection, 40 mg injection
- Amsoprin Acetylsalicylic acid (Aspirin) · 300 mg tablet
- Amsotose Iron polymaltose complex + Folic acid, Iron polymaltose complex · 100 mg elemental iron + 0.35 mg folic acid tablet, 50 mg/5 mL suspension
- Amsozid Isoniazid · 300 mg tablet
- Amsozide-100 Isoniazid · 100 mg tablet
- Amvax B Hepatitis B vaccine (recombinant HBsAg) · 10 mcg/0.5 mL injection, 20 mcg/1 mL vaccine
- Awzi Azithromycin · 200 mg/5 mL suspension, 250 mg capsule
- Bett Tetanus toxoid adsorbed vaccine · >40 IU/0.5 mL injection
- Cardrin Acetylsalicylic acid (Aspirin) · 150 mg tablet, 75 mg tablet, 81 mg tablet
- Ceftapen Ceftazidime · 1 g injection, 250 mg injection
- Cesod Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
- Ciprox Ciprofloxacin · 100 mg tablet, 250 mg tablet, 500 mg tablet
- ComBe Five Diphtheria + Tetanus + Pertussis + Hepatitis B + Haemophilus influenzae type b vaccine · 25 Lf + 5.5 Lf + 16 IOU + 12.5 mcg HBsAg + 11 mcg Hib PRP per 0.5 mL vaccine
- Curoxime Cefuroxime · 1.5 g injection, 250 mg injection, 750 mg injection
- Damex Cough Aminophylline + Diphenhydramine + Ammonium chloride + Menthol · 32 mg + 8 mg + 30 mg + 0.98 mg/5 mL syrup
- Entvir Entecavir · 0.5 mg tablet
- Euvichol-Plus Cholera vaccine (inactivated, oral; Vibrio cholerae O1 and O139) · 1.5 mL dose vaccine
- Fanim-5 Folic acid · 5 mg tablet
- Fefan Ferrous sulfate + Folic acid · 150 mg + 0.5 mg tablet
- Fefan DS Ferrous sulfate + Folic acid · 300 mg + 5 mg tablet
- Group ACYW135 Meningococcal Polysaccharide Vaccine Meningococcal polysaccharide vaccine, groups A/C/Y/W-135 · 50 mcg of each A, C, Y and W-135 polysaccharide / 0.5 mL dose injection
- Hemofer Ferrous sulfate + Folic acid · 150 mg + 0.5 mg tablet
- Hyzonate Hydrocortisone · 100 mg injection, 250 mg injection, 500 mg injection
- Imatet Purified Tetanus Toxoid not less than · 40 IU injection
- IMMUNOHBS Human hepatitis B immunoglobulin · 180 IU/mL injection
- Immunorho Human anti-D immunoglobulin · 300 mcg/2 mL (1500 IU) injection
- Irosul Ferrous sulfate · 200 mg tablet
- Levam Levamisole · 40 mg tablet
- Loramine Loratadine · 10 mg tablet, 5 mg/5 mL syrup
- Metro Metronidazole, Metronidazole (Benzoate) · 200 mg tablet, 200 mg/5 mL suspension, 400 mg tablet
- MMR Vaccine Measles + Mumps + Rubella live attenuated vaccine · Measles ≥1000 CCID50 + Rubella ≥1000 CCID50 + Mumps ≥5000 CCID50 / 0.5 mL dose vaccine
- Myconil Nystatin · 100,000 IU/mL drops
- Myconil s Nystatin · 100000 IU pessary
- Myconil Vaginal Nystatin · 100000 IU pessary
- Naciline Ampicillin · 250 mg injection, 500 mg injection
- Neo-Cotecxin Artemether + Lumefantrine · 20 mg + 120 mg tablet
- Neo-Cotecxin DS Artemether · 80 mg tablet
- Neo-Cotecxin Forte Artemether · 40 mg tablet
- Newmac Clarithromycin · 125 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
- Omepral Omeprazole · 20 mg capsule
- Oraznic Zinc sulfate · 20 mg tablet
- Orvastin Atorvastatin · 10 mg tablet, 20 mg tablet, 40 mg tablet
- Oxiflox Moxifloxacin · 400 mg tablet
- Ranitid Ranitidine · 150 mg tablet
- Typbar Typhoid Vi polysaccharide vaccine · 25 mcg/0.5 mL injection
- Vespin Amlodipine · 10 mg tablet, 5 mg tablet
- Vitam Thiamine + Riboflavin + Pyridoxine + Cyanocobalamin + Nicotinamide + Calcium pantothenate + Ascorbic acid · 15 mg + 10 mg + 5 mg + 4 mcg + 100 mg + 20 mg + 500 mg tablet
- Worex Mebendazole · 100 mg tablet, 500 mg tablet
Amson Vaccines & Pharma: common questions
How many products does Amson Vaccines & Pharma have in Pakistan?
Amson Vaccines & Pharma (Pvt.) Ltd has 123 registered medicine presentations in Pakistan, sold under 63 brands and covering 55 generic medicines.
What are the main brands of Amson Vaccines & Pharma?
By number of registered strengths and packs, its largest brands are Cesod (Ceftriaxone), Amsonate (Methylprednisolone), Amvax B (Hepatitis B vaccine (recombinant HBsAg)), Ciprox (Ciprofloxacin) and Worex (Mebendazole). This is not a sales ranking.
Which therapy areas does Amson Vaccines & Pharma cover?
The most products are in Anti-infectives (50), Vitamins, minerals & nutrition (21), Vaccines & immunologicals (14), Respiratory & allergy (9) and Pain & musculoskeletal (7).
Where can I see Amson Vaccines & Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.